BioAtla (BCAB)
NASDAQ:BCAB
US Market
Holding BCAB?
Track your performance easily

BioAtla (BCAB) Financial Statements

510 Followers

BioAtla Financial Overview

BioAtla's market cap is currently ―. The company's EPS TTM is $-1.699; its P/E ratio is -1.39; BioAtla is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.59M$ -21.07M$ -23.23M$ -28.54M$ -35.02M
EBITDA$ -10.36M$ -20.84M$ -22.99M$ -28.17M$ -34.75M
Net Income Common Stockholders$ -10.59M$ -21.07M$ -23.23M$ -26.94M$ -33.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 56.52M$ 61.66M$ 80.63M$ 111.47M$ 141.28M
Total Assets$ 62.24M$ 68.64M$ 89.20M$ 119.66M$ 151.36M
Total Debt$ 1.25M$ 1.66M$ 1.92M$ 2.46M$ 2.85M
Net Debt$ -55.27M$ -60.00M$ -78.71M$ -109.01M$ -138.44M
Total Liabilities$ 39.27M$ 37.27M$ 39.48M$ 48.99M$ 56.66M
Stockholders Equity$ 22.97M$ 31.37M$ 49.72M$ 70.67M$ 94.70M
Cash Flow-
Free Cash Flow$ -5.13M$ -19.19M$ -30.83M$ -29.93M$ -27.37M
Operating Cash Flow$ -5.13M$ -19.19M$ -30.83M$ -29.92M$ -27.34M
Investing Cash Flow---$ -8.00K$ -25.00K
Financing Cash Flow$ -14.00K$ 225.00K$ -13.00K$ 119.00K$ -41.00K
Currency in USD

BioAtla Earnings and Revenue History

BioAtla Debt to Assets

BioAtla Cash Flow

BioAtla Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis